Comprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive disease

Journal of Virology

Volumn 85, Issue 3, 2011, Pages 1287-1297

  Schulze Zur Wiesch, Julian ^a,b   Thomssen, Adriana ^a,b   Hartjen, Philip ^a,b   Tóth, Ilona ^a,b   Lehmann, Clara ^c   Meyer Olson, Dirk ^d   Colberg, Kristina ^a,b   Frerk, Sebastian ^a,b   Babikir, Dalia ^a,b   Schmiedel, Stefan ^a   Degen, Olaf ^a   Mauss, Stefan ^e   Rockstroh, Jürgen ^f   Staszewski, Schlomo ^g   Khaykin, Pavel ^g   Strasak, Alexander ^h   Lohse, Ansgar W ^a   Fätkenheuer, Gerd ^c   Hauber, Joachim ^b   Van Lunzen, Jan ^a,b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

^d HANNOVER MEDICAL SCHOOL   (Germany)

^e Center for HIV and Hepatogastroenterology   (Germany)

^f UNIVERSITY HOSPITAL BONN   (Germany)

^g GOETHE UNIVERSITY   (Germany)

^h Informatics and Health Economics ^*  (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CD28 ANTIGEN; CD39 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INDUCIBLE COSTIMULATOR; INTERLEUKIN 7 RECEPTOR; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BLOOD SAMPLING; CD25+ T LYMPHOCYTE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREGULATION; IN VITRO STUDY; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; T CELL DEPLETION; VIRUS LOAD;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; APYRASE; DISEASE PROGRESSION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; T-LYMPHOCYTES, REGULATORY; VIRAL LOAD;

EID: 78651396992     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01758-10     Document Type: Article

References (62)

1. Alimonti, J. B., T. B. Ball, and K. R. Fowke. 2003. Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS. J. Gen. Virol. 84:1649-1661.
2. Andersson, J., A. Boasso, J. Nilsson, R. Zhang, N. J. Shire, S. Lindback, G. M. Shearer, and C. A. Chougnet. 2005. The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients. J. Immunol. 174:3143-3147.
3. Barat, C., G. Martin, A. R. Beaudoin, J. Sevigny, and M. J. Tremblay. 2007. The nucleoside triphosphate diphosphohydrolase-1/CD39 is incorporated into human immunodeficiency type 1 particles, where it remains biologically active. J. Mol. Biol. 371:269-282.
4. Beigi, R. D., S. B. Kertesy, G. Aquilina, and G. R. Dubyak. 2003. Oxidized ATP (oATP) attenuates proinflammatory signaling via P2 receptor-independent mechanisms. Br. J. Pharmacol. 140:507-519.
5. Belkaid, Y., and B. T. Rouse. 2005. Natural regulatory T cells in infectious disease. Nat. Immunol. 6:353-360.
6. Bi, X., Y. Suzuki, H. Gatanaga, and S. Oka. 2009. High frequency and proliferation of CD4+ FOXP3+ Treg in HIV-1-infected patients with low CD4 counts. Eur. J. Immunol. 39:301-309.
7. Bland, J. M., and D. G. Altman. 1995. Multiple significance tests: the Bonferroni method. BMJ 310:170.
8. Borsellino, G., M. Kleinewietfeld, D. Di Mitri, A. Sternjak, A. Diamantini, R. Giometto, S. Hopner, D. Centonze, G. Bernardi, M. L. Dell'Acqua, P. M. Rossini, L. Battistini, O. Rotzschke, and K. Falk. 2007. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 110:1225-1232.
9. Cao, W., B. D. Jamieson, L. E. Hultin, P. M. Hultin, and R. Detels. 2009. Regulatory T cell expansion and immune activation during untreated HIV type 1 infection are associated with disease progression. AIDS Res. Hum. Retrovir. 25:183-191.
10. Card, C. M., P. J. McLaren, C. Wachihi, J. Kimani, F. A. Plummer, and K. R. Fowke. 2009. Decreased immune activation in resistance to HIV-1 infection is associated with an elevated frequency of CD4(+)CD25(+)FOXP3(+) regulatory T cells. J. Infect. Dis. 199:1318-1322.
11. Chase, A. J., H. C. Yang, H. Zhang, J. N. Blankson, and R. F. Siliciano. 2008. Preservation of FoxP3+ regulatory T cells in the peripheral blood of human immunodeficiency virus type 1-infected elite suppressors correlates with low CD4+ T-cell activation. J. Virol. 82:8307-8315.
12. Deaglio, S., K. M. Dwyer, W. Gao, D. Friedman, A. Usheva, A. Erat, J. F. Chen, K. Enjyoji, J. Linden, M. Oukka, V. K. Kuchroo, T. B. Strom, and S. C. Robson. 2007. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 204:1257-1265.
13. Deeks, S. G., and B. D. Walker. 2007. Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity 27:406-416.
14. Del Pozo-Balado Mdel, M., M. Leal, G. Mendez-Lagares, and Y. M. Pacheco. 2010. CD4(+)CD25(+/hi)CD127(lo) phenotype does not accurately identify regulatory T cells in all populations of HIV-infected persons. J. Infect. Dis. 201:331-335.
15. Douek, D. C. 2003. Disrupting T-cell homeostasis: how HIV-1 infection causes disease. AIDS Rev. 5:172-177.
16. Elliott, M. R., F. B. Chekeni, P. C. Trampont, E. R. Lazarowski, A. Kadl, S. F. Walk, D. Park, R. I. Woodson, M. Ostankovich, P. Sharma, J. J. Lysiak, T. K. Harden, N. Leitinger, and K. S. Ravichandran. 2009. Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 461:282-286.
17. Epple, H. J., C. Loddenkemper, D. Kunkel, H. Troger, J. Maul, V. Moos, E. Berg, R. Ullrich, J. D. Schulzke, H. Stein, R. Duchmann, M. Zeitz, and T. Schneider. 2006. Mucosal but not peripheral FOXP3+ regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART. Blood 108:3072-3078.
18. Fazekasde St. Groth, B., and A. L. Landay. 2008. Regulatory T cells in HIV infection: pathogenic or protective participants in the immune response? AIDS 22:671-683.
19. Fontenot, J. D., M. A. Gavin, and A. Y. Rudensky. 2003. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4:330-336.
20. Fraser, J. H., M. Rincon, K. D. McCoy, and G. Le Gros. 1999. CTLA4 ligation attenuates AP-1, NFAT and NF-kappaB activity in activated T cells. Eur. J. Immunol. 29:838-844.
21. Ganesh, L., E. Burstein, A. Guha-Niyogi, M. K. Louder, J. R. Mascola, L. W. Klomp, C. Wijmenga, C. S. Duckett, and G. J. Nabel. 2003. The gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytes. Nature 426:853-857.
22. Grant, C., U. Oh, K. Fugo, N. Takenouchi, C. Griffith, K. Yao, T. E. Newhook, L. Ratner, and S. Jacobson. 2006. Foxp3 represses retroviral transcription by targeting both NF-kappaB and CREB pathways. PLoS Pathog. 2:e33.
23. Hazenberg, M. D., S. A. Otto, D. Hamann, M. T. Roos, H. Schuitemaker, R. J. de Boer, and F. Miedema. 2003. Depletion of naive CD4 T cells by CXCR4-using HIV-1 variants occurs mainly through increased T-cell death and activation. AIDS 17:1419-1424.
24. Reference deleted.
25. Kassiotis, G., and A. O'Garra. 2008. Immunology. Immunity benefits from a little suppression. Science 320:1168-1169.
26. Kaufmann, D. E., and B. D. Walker. 2009. PD-1 and CTLA-4 inhibitory cosignaling pathways in HIV infection and the potential for therapeutic intervention. J. Immunol. 182:5891-5897.
27. Kinter, A., J. McNally, L. Riggin, R. Jackson, G. Roby, and A. S. Fauci. 2007. Suppression of HIV-specific T cell activity by lymph node CD25+ regulatory T cells from HIV-infected individuals. Proc. Natl. Acad. Sci. U. S. A. 104:3390-3395.
28. Kinter, A. L., R. Horak, M. Sion, L. Riggin, J. McNally, Y. Lin, R. Jackson, A. O'Shea, G. Roby, C. Kovacs, M. Connors, S. A. Migueles, and A. S. Fauci. 2007. CD25+ regulatory T cells isolated from HIV-infected individuals suppress the cytolytic and nonlytic antiviral activity of HIV-specific CD8+ T cells in vitro. AIDS Res. Hum. Retrovir. 23:438-450.
29. Kohyama, M., D. Sugahara, S. Sugiyama, H. Yagita, K. Okumura, and N. Hozumi. 2004. Inducible costimulator-dependent IL-10 production by regulatory T cells specific for self-antigen. Proc. Natl. Acad. Sci. U. S. A. 101:4192-4197.
30. Kumar, V., and A. Sharma. 2009. Adenosine: an endogenous modulator of innate immune system with therapeutic potential. Eur. J. Pharmacol. 616:7-15.
31. Lawn, S. D., S. T. Butera, and T. M. Folks. 2001. Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection. Clin. Microbiol. Rev. 14:753-777.
32. Leal, D. B., C. A. Streher, M. Bertoncheli Cde, L. F. Carli, C. A. Leal, J. E. da Silva, V. M. Morsch, and M. R. Schetinger. 2005. HIV infection is associated with increased NTPDase activity that correlates with CD39-positive lymphocytes. Biochim. Biophys. Acta 1746:129-134.
33. Letvin, N. L., and B. D. Walker. 2003. Immunopathogenesis and immunotherapy in AIDS virus infections. Nat. Med. 9:861-866.
34. Lim, A., M. A. French, and P. Price. 2009. CD4+ and CD8+ T cells expressing FoxP3 in HIV-infected patients are phenotypically distinct and influenced by disease severity and antiretroviral therapy. J. Acquir. Immune. Defic. Syndr. 51:248-257.
35. Lund, J. M., L. Hsing, T. T. Pham, and A. Y. Rudensky. 2008. Coordination of early protective immunity to viral infection by regulatory T cells. Science 320:1220-1224.
36. Maliszewski, C. R., G. J. Delespesse, M. A. Schoenborn, R. J. Armitage, W. C. Fanslow, T. Nakajima, E. Baker, G. R. Sutherland, K. Poindexter, C. Birks, et al. 1994. The CD39 lymphoid cell activation antigen. Molecular cloning and structural characterization. J. Immunol. 153:3574-3583.
37. Mandapathil, M., B. Hilldorfer, M. J. Szczepanski, M. Czystowska, M. Szajnik, J. Ren, S. Lang, E. K. Jackson, E. Gorelik, and T. L. Whiteside. 2010. Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cells. J. Biol. Chem. 285:7176-7186.
38. Moncrieffe, H., K. Nistala, Y. Kamhieh, J. Evans, A. Eddaoudi, S. Eaton, and L. R. Wedderburn. 2010. High expression of the ectonucleotidase CD39 on T cells from the inflamed site identifies two distinct populations, one regulatory and one memory T cell population. J. Immunol. 185:134-143.
39. Moreno-Fernandez, M. E., W. Zapata, J. T. Blackard, G. Franchini, and C. A. Chougnet. 2009. Human regulatory T cells are targets for human immunodeficiency virus (HIV) infection, and their susceptibility differs depending on the HIV type 1 strain. J. Virol. 83:12925-12933.
40. Ndhlovu, L. C., F. E. Leal, I. G. Eccles-James, A. R. Jha, M. Lanteri, P. J. Norris, J. D. Barbour, D. J. Wachter, J. Andersson, K. Tasken, E. A. Torheim, E. M. Aandahl, E. G. Kallas, and D. F. Nixon. 2010. A novel human CD4+ T-cell inducer subset with potent immunostimulatory properties. Eur. J. Immunol. 40:134-141.
41. Nigam, P., V. Velu, S. Kannanganat, L. Chennareddi, S. Kwa, M. Siddiqui, and R. R. Amara. 2010. Expansion of FOXP3+ CD8 T cells with suppressive potential in colorectal mucosa following a pathogenic simian immunodeficiency virus infection correlates with diminished antiviral T cell response and viral control. J. Immunol. 184:1690-1701.
42. Nilsson, J., A. Boasso, P. A. Velilla, R. Zhang, M. Vaccari, G. Franchini, G. M. Shearer, J. Andersson, and C. Chougnet. 2006. HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS. Blood 108:3808-3817.
43. Nixon, D. F., E. M. Aandahl, and J. Michaelsson. 2005. CD4+CD25+ regulatory T cells in HIV infection. Microbes Infect. 7:1063-1065.
44. Oswald-Richter, K., S. M. Grill, M. Leelawong, M. Tseng, S. A. Kalams, T. Hulgan, D. W. Haas, and D. Unutmaz. 2007. Identification of a CCR5-expressing T cell subset that is resistant to R5-tropic HIV infection. PLoS Pathog. 3:e58.
45. Oswald-Richter, K., S. M. Grill, N. Shariat, M. Leelawong, M. S. Sundrud, D. W. Haas, and D. Unutmaz. 2004. HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells. PLoS Biol. 2:E198.
46. Pereyra, F., M. M. Addo, D. E. Kaufmann, Y. Liu, T. Miura, A. Rathod, B. Baker, A. Trocha, R. Rosenberg, E. Mackey, P. Ueda, Z. Lu, D. Cohen, T. Wrin, C. J. Petropoulos, E. S. Rosenberg, and B. D. Walker. 2008. Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. J. Infect. Dis. 197:563-571.
47. Prendergast, A., J. G. Prado, Y. H. Kang, F. Chen, L. A. Riddell, G. Luzzi, P. Goulder, and P. Klenerman. 2010. HIV-1 infection is characterized by profound depletion of CD161+ Th17 cells and gradual decline in regulatory T cells. AIDS 24:491-502.
48. Riley, J. L., C. H. June, and B. R. Blazar. 2009. Human T regulatory cell therapy: take a billion or so and call me in the morning. Immunity 30:656-665.
49. Roncarolo, M. G., and S. Gregori. 2008. Is FOXP3 a bona fide marker for human regulatory T cells? Eur. J. Immunol. 38:925-927.
50. Rouse, B. T., P. P. Sarangi, and S. Suvas. 2006. Regulatory T cells in virus infections. Immunol. Rev. 212:272-286.
51. Ruckwardt, T. J., K. L. Bonaparte, M. C. Nason, and B. S. Graham. 2009. Regulatory T cells promote early influx of CD8+ T cells in the lungs of respiratory syncytial virus-infected mice and diminish immunodominance disparities. J. Virol. 83:3019-3028.
52. Sakaguchi, S., N. Sakaguchi, M. Asano, M. Itoh, and M. Toda. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155:1151-1164.
53. Schulze zur Wiesch, J., G. M. Lauer, C. L. Day, A. Y. Kim, K. Ouchi, J. E. Duncan, A. G. Wurcel, J. Timm, A. M. Jones, B. Mothe, T. M. Allen, B. McGovern, L. Lewis-Ximenez, J. Sidney, A. Sette, R. T. Chung, and B. D. Walker. 2005. Broad repertoire of the CD4+ Th cell response in spontaneously controlled hepatitis C virus infection includes dominant and highly promiscuous epitopes. J. Immunol. 175:3603-3613.
54. Seddiki, N., and A. D. Kelleher. 2008. Regulatory T cells in HIV infection: who's suppressing what? Curr. Infect. Dis. Rep. 10:252-258.
55. Seddiki, N., B. Santner-Nanan, J. Martinson, J. Zaunders, S. Sasson, A. Landay, M. Solomon, W. Selby, S. I. Alexander, R. Nanan, A. Kelleher, and B. Fazekas de St. Groth. 2006. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J. Exp. Med. 203:1693-1700.
56. Selliah, N., M. Zhang, S. White, P. Zoltick, B. E. Sawaya, T. H. Finkel, and R. Q. Cron. 2008. FOXP3 inhibits HIV-1 infection of CD4 T-cells via inhibition of LTR transcriptional activity. Virology 381:161-167.
57. Sitkovsky, M., D. Lukashev, S. Deaglio, K. Dwyer, S. C. Robson, and A. Ohta. 2008. Adenosine A2A receptor antagonists: blockade of adenosinergic effects and T regulatory cells. Br. J. Pharmacol. 153(Suppl. 1):S457-S464.
58. Tenorio, A. R., J. Martinson, D. Pollard, L. Baum, and A. Landay. 2008. The relationship of T-regulatory cell subsets to disease stage, immune activation, and pathogen-specific immunity in HIV infection. J. Acquir. Immune Defic. Syndr. 48:577-580.
59. Terzieva, V. 2008. Regulatory T cells and HIV-1 infection. Viral Immunol. 21:285-291.
60. Tran, T. A., M. G. de Goer de Herve, H. Hendel-Chavez, B. Dembele, E. Le Nevot, K. Abbed, C. Pallier, C. Goujard, J. Gasnault, J. F. Delfraissy, A. M. Balazuc, and Y. Taoufik. 2008. Resting regulatory CD4 T cells: a site of HIV persistence in patients on long-term effective antiretroviral therapy. PLoS One 3:e3305.
61. Tsunemi, S., T. Iwasaki, T. Imado, S. Higasa, E. Kakishita, T. Shirasaka, and H. Sano. 2005. Relationship of CD4+CD25+ regulatory T cells to immune status in HIV-infected patients. AIDS 19:879-886.
62. Weiss, L., V. Donkova-Petrini, L. Caccavelli, M. Balbo, C. Carbonneil, and Y. Levy. 2004. Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood 104:3249-3256.